| # | Side effect | Count |
|---|---|---|
| 0 | PRODUCT DOSE OMISSION ISSUE | 135 |
| 1 | NO ADVERSE EVENT | 78 |
| 2 | POOR VENOUS ACCESS | 72 |
| 3 | INTENTIONAL DOSE OMISSION | 38 |
| 4 | DEVICE ISSUE | 35 |
| 5 | COVID-19 | 23 |
| 6 | MALAISE | 22 |
| 7 | PYREXIA | 20 |
| 8 | VOMITING | 17 |
| 9 | ILLNESS | 14 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | CYSTATIN C INCREASED | 4 | 0.0312 |
| 1 | CATHETER SITE EROSION | 2 | 0.0220 |
| 2 | PELVIC MISALIGNMENT | 1 | 0.0196 |
| 3 | CATHETER SITE OEDEMA | 2 | 0.0183 |
| 4 | CATHETER SITE DISCOLOURATION | 2 | 0.0164 |
| 5 | MUSCLE FIBROSIS | 1 | 0.0137 |
| 6 | CATHETER SITE SCAB | 1 | 0.0093 |
| 7 | POOR VENOUS ACCESS | 72 | 0.0070 |
| 8 | CATHETER SITE WARMTH | 1 | 0.0061 |
| 9 | EXPOSURE TO SARS-COV-2 | 10 | 0.0059 |